Dupilumab, sold under the brand name Dupixent, is a monoclonal antibody blocking interleukin 4 and interleukin 13, used for allergic diseases such as...
22 KB (1,789 words) - 04:29, 16 July 2024
reported to be effective. Dupilumab (Dupixent) was approved for medical use in the United States in September 2022. Dupilumab is the first medication approved...
14 KB (1,486 words) - 04:29, 14 August 2024
desensitization and therapy, dupilumab (Dupixent) was show to be the most effective across six different patient-important outcomes. Dupilumab and omalizumab have...
50 KB (5,530 words) - 02:09, 6 June 2024
azathioprine, and methotrexate. Dupilumab is a new medication that improves eczema lesions, especially moderate to severe eczema. Dupilumab, a monoclonal antibody...
68 KB (6,964 words) - 16:34, 12 August 2024
are still limitations to the use of anti-IL-13 monoclonal antibodies. Dupilumab is a newer drug that targets the shared receptor of IL-4 and IL-13, IL4Rα...
20 KB (2,271 words) - 04:25, 12 May 2024
inhibits PDGF-BB in hypereosinophilic leukemia Monoclonal antibodies such as dupilumab and lebrikizumab target IL-13 and its receptor, which reduces eosinophilic...
28 KB (3,105 words) - 16:05, 11 July 2024
have showed that abrocitinib improved the EASI scores in comparison with dupilumab, even in the second week of treatment. A faster onset of Investigator's...
27 KB (2,697 words) - 02:16, 16 July 2024
July 2015, It is reported to cost $4,500 to $8,000 per year. Dupixent (dupilumab injection) is for the treatment of adolescent and adult patients' atopic...
26 KB (2,283 words) - 11:13, 25 August 2024
for stable angina, marketed by Gilead Sciences. – Dermatology Dupixent (Dupilumab), for eczema, marketed by Regeneron. Dynabac (Dirithromycin), for acute...
91 KB (8,778 words) - 06:05, 10 August 2024
cases may need systemic medicines such as cyclosporin, methotrexate, dupilumab or baricitinib. Other names of the condition include "infantile eczema"...
90 KB (9,344 words) - 17:45, 20 August 2024
capsule". dailymed.nlm.nih.gov. Retrieved 2021-07-01. "DailyMed - DUPIXENT- dupilumab injection, solution". dailymed.nlm.nih.gov. Retrieved 2021-07-01. "DailyMed...
11 KB (842 words) - 13:15, 12 February 2024
unknown origin. However, there are clinical trials currently underway with dupilumab which is thought to alleviate itch by acting on the IL-4 receptor on sensory...
34 KB (3,721 words) - 20:43, 18 August 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
3 KB (215 words) - 23:23, 12 June 2024
in symptoms. In May 2022, U.S. Food and Drug Administration approved dupilumab (Dupixent) to treat eosinophilic esophagitis (EoE) in adults and pediatric...
32 KB (3,642 words) - 23:52, 17 June 2024
year are unknown. Monoclonal antibody injections such as mepolizumab, dupilumab, or omalizumab may be useful in those with poorly controlled atopic asthma...
167 KB (18,027 words) - 18:45, 24 August 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
23 KB (2,330 words) - 16:48, 11 May 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
50 KB (5,493 words) - 21:20, 29 July 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
34 KB (3,429 words) - 17:31, 18 August 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
15 KB (1,348 words) - 15:48, 18 August 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
181 KB (17,324 words) - 15:24, 6 August 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
50 KB (6,052 words) - 05:30, 23 August 2024
Binetrakin Interleukin 4 Interleukin 13 Antagonists: Pitrakinra Antibodies: Dupilumab Pascolizumab IL-5 Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies:...
43 KB (3,662 words) - 19:35, 12 July 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
3 KB (192 words) - 00:44, 9 June 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
27 KB (2,274 words) - 02:54, 22 March 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
34 KB (3,039 words) - 08:54, 4 June 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
12 KB (1,105 words) - 14:42, 25 August 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
74 KB (7,439 words) - 09:52, 5 August 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
201 KB (19,969 words) - 20:11, 25 August 2024
gluconate Collagen Crisaborole Cromoglicic acid Deoxycholic acid Diclofenac Dupilumab Estrogens (e.g., estradiol) Glycopyrronium tosylate Hyaluronic acid Hydrogen...
25 KB (2,427 words) - 10:40, 12 August 2024
IL-13-specific blockers: Lebrikizumab Tralokinumab Dual IL-4 and IL-13 blockers: Dupilumab IgE-blockers: Ligelizumab Omalizumab Allen, Judith E.; Sutherland, Tara...
5 KB (560 words) - 00:25, 17 July 2024